Carl Zeiss Meditec AG

AFXA

Company Profile

  • Business description

    Carl Zeiss Meditec is one of the largest visioncare technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up about 75% of sales in 2025, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.

  • Contact

    Goschwitzer Strasse 51-52
    JenaTH07745
    DEU

    T: +49 3641220115

    https://www.zeiss.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    30 September 2026

    Employees

    5,798

Stocks News & Analysis

stocks

Steep downgrade for wide moat share

Regulatory pressures squeeze growth outlook for wide moat ASX share.
stocks

The strange effect of the 30% minimum capital gains tax

How the proposed CGT floor creates unexpected outcomes across different incomes.
stocks

ASX restaurant chain remains cheap

Is the market overlooking this undervalued fast food chain?

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,979.3038.700.43%
CAC 408,252.66183.58-2.18%
DAX 4024,897.45567.80-2.23%
Dow JONES (US)52,218.19706.96-1.34%
FTSE 10010,489.04176.84-1.66%
HKSE24,199.46702.572.99%
NASDAQ25,705.78112.91-0.44%
Nikkei 22566,819.051,437.91-2.11%
NZX 50 Index13,665.1897.61-0.71%
S&P 5007,457.0746.78-0.62%
S&P/ASX 2008,785.1047.500.54%
SSE Composite Index3,970.8819.36-0.49%

Market Movers